{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:19Z","timestamp":1788952399838,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2025-RC330-01"],"award-info":[{"award-number":["2025-RC330-01"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFE0214800"],"award-info":[{"award-number":["2024YFE0214800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ebiom.2026.106439","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:14Z","timestamp":1787242274000},"page":"106439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The VAccine cLinical study reporting gUidEline: the VALUE checklist with explanation and elaboration"],"prefix":"10.1016","volume":"131","author":[{"given":"Yuting","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-2460","authenticated-orcid":false,"given":"Yanfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Rodewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-2168","authenticated-orcid":false,"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7303","key":"10.1016\/j.ebiom.2026.106439_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106439_bib2","article-title":"Clinical trials and clinical research: a comprehensive review","volume":"15","author":"Kandi","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106439_bib3","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S1473-3099(21)00705-2","article-title":"The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations","volume":"22","author":"Goossens","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106439_bib4","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1080\/21645515.2021.1945901","article-title":"Landscape and progress of global COVID-19 vaccine development","volume":"17","author":"Huang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106439_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106439_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106439_bib8","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106439_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"9596","key":"10.1016\/j.ebiom.2026.106439_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106439_bib11","article-title":"A review of adherence and predictors of adherence to the CONSORT statement in the reporting of tuberculosis vaccine trials","volume":"8","author":"Ngah","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106439_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2026.106439_bib13","author":"Bian"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106439_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032829","article-title":"Use of Delphi in health sciences research: a narrative review","volume":"102","author":"Shang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106439_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106439_bib16","article-title":"Adverse events reporting quality of randomized controlled trials of COVID-19 vaccine using the CONSORT criteria for reporting harms: a systematic review","volume":"10","author":"Yuniar","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106439_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/infdis\/jiac038","article-title":"Immunogenicity of a third scheduled dose of rotarix in Australian Indigenous infants: a phase IV, double-blind, randomized, placebo-controlled clinical trial","volume":"226","author":"Middleton","year":"2022","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106439_bib18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S1473-3099(21)00153-5","article-title":"Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial","volume":"21","author":"Chapman","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106439_bib19","article-title":"The quality of reporting of randomized controlled trials of HuatuoZaizao pill for stroke","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106439_bib20","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/INF.0000000000002124","article-title":"Antibody persistence up to 3 years after primary immunization with inactivated Japanese encephalitis vaccine IXIARO in Philippine children and effect of a booster dose","volume":"37","author":"Kadlecek","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106439_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011926","article-title":"Assessment of the quality of reporting in abstracts of randomized controlled trials published in five leading Chinese medical journals","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106439_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005068","article-title":"Assessment of the quality of reporting in randomised controlled trials of acupuncture in the Korean literature using the CONSORT statement and STRICTA guidelines","volume":"4","author":"Kim","year":"2014","journal-title":"BMJ Open"},{"issue":"27","key":"10.1016\/j.ebiom.2026.106439_bib23","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2018.08.009","article-title":"Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: a randomized, placebo-controlled trial with 78-month follow-up","volume":"37","author":"Wei","year":"2019","journal-title":"Vaccine"},{"issue":"10261","key":"10.1016\/j.ebiom.2026.106439_bib24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","article-title":"Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (\u226565 years): two multicentre, randomised phase 3 trials","volume":"396","author":"Ward","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106439_bib25","article-title":"Assessment of reporting quality in randomized controlled trials of acupuncture for primary insomnia with CONSORT statement and STRICTA guidelines","volume":"2022","author":"Yang","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106439_bib26","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1080\/21645515.2019.1613127","article-title":"A phase 2\/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam","volume":"15","author":"Lan","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106439_bib27","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.650","article-title":"Primary outcome reporting in clinical trials for older adults with depression","volume":"10","author":"Rodrigues","year":"2024","journal-title":"BJPsych Open"},{"key":"10.1016\/j.ebiom.2026.106439_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103962","article-title":"Reporting and data sharing level for COVID-19 vaccine trials: a cross-sectional study","volume":"78","author":"Duan","year":"2022","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106439_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16097-3","article-title":"Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants","volume":"12","author":"Vadrevu","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106439_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cmi.2018.12.033","article-title":"Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial","volume":"25","author":"Hao","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"10.1016\/j.ebiom.2026.106439_bib31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106439_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106439_bib33","article-title":"Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults","volume":"8","author":"Stevanovic","year":"2020","journal-title":"Ther Adv Vaccines Immunother"},{"issue":"10120","key":"10.1016\/j.ebiom.2026.106439_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106439_bib35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/curroncol30020160","article-title":"Adherence to CONSORT guidelines and reporting of the determinants of external validity in clinical oncology randomized controlled trials: a review of trials published in four major journals between 2013 and 2015","volume":"30","author":"Audet","year":"2023","journal-title":"Curr Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106439_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(22)00144-X","article-title":"Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial","volume":"22","author":"Smolenov","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106439_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c723","article-title":"The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed","volume":"340","author":"Hopewell","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106439_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ebiom.2018.01.007","article-title":"Acetylcholine receptor antibody titers and clinical course after influenza vaccination in patients with myasthenia gravis: a double-blind randomized controlled trial (ProPATIent-Trial)","volume":"28","author":"Tackenberg","year":"2018","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106439_bib39","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1080\/21645515.2019.1581536","article-title":"Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions","volume":"15","author":"Moris","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106439_bib40","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jpurol.2021.09.012","article-title":"Quality of reporting for pilot randomized controlled trials in the pediatric urology literature-a systematic review","volume":"17","author":"McGrath","year":"2021","journal-title":"J Pediatr Urol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106439_bib41","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/cid\/ciy242","article-title":"Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults with CD4+ cell counts >200 Cells\/mL Virologically Suppressed on Antiretroviral Therapy","volume":"67","author":"Benson","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106439_bib42","first-page":"10","article-title":"Intralesional injection of the measles-mumps-rubella vaccine into resistant palmoplantar warts: a randomized controlled trial","volume":"44","author":"Rezai","year":"2019","journal-title":"Iran J Med Sci"},{"issue":"47","key":"10.1016\/j.ebiom.2026.106439_bib43","first-page":"70772","article-title":"Current clinical status of new COVID-19 vaccines and immunotherapy","volume":"29","author":"Nagpal","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106439_bib44","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1473-3099(21)00263-2","article-title":"Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities","volume":"21","author":"Dal-R\u00e9","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106439_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v13071397","article-title":"An appraisal of the current scenario in vaccine research for COVID-19","volume":"13","author":"Chong","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106439_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"40","key":"10.1016\/j.ebiom.2026.106439_bib47","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2022.08.036","article-title":"Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults","volume":"40","author":"Fraiman","year":"2022","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.ebiom.2026.106439_bib48","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:27:20Z","timestamp":1788949640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S2352396426003233"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106439","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The VAccine cLinical study reporting gUidEline: the VALUE checklist with explanation and elaboration","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106439"}}